{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:45:11Z","timestamp":1747172711948,"version":"3.40.5"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJEM"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>A 53-year-old male presents with cough, fever, and myalgias for 7 days. Vitals include temperature, 38.0\u00b0C; heart rate, 110; blood pressure, 118\/70\u00a0mm Hg; respiration rate, 28; and oxygen saturation 83% on room air. His only past medical history is hypertension. Your community is in the midst of the coronavirus disease 2019 (COVID-19) pandemic. The patient is hypoxic but responds to oxygen supplementation with nasal cannula and a face mask. His chest x-ray demonstrates multifocal infiltrates. Are there any therapeutic agents currently available for COVID-19?<\/jats:p>","DOI":"10.1017\/cem.2020.403","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T03:31:07Z","timestamp":1590118267000},"page":"591-594","source":"Crossref","is-referenced-by-count":1,"title":["Just the facts: What drugs are safe and effective for COVID-19?"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Y.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"S1481803520004030_ref1a","unstructured":"References S4\u2013S16 are found in Supplementary Material."},{"key":"S1481803520004030_ref1","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"S1481803520004030_ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa478"},{"key":"S1481803520004030_ref3","unstructured":"3. Liverpool Drug Interactions Group. Interactions with experimental COVID-19 therapies. Available at: https:\/\/www.covid19-druginteractions.org (accessed March 12, 2020)."}],"container-title":["CJEM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1481803520004030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T23:43:03Z","timestamp":1609458183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1481803520004030\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1481803520004030"],"URL":"https:\/\/doi.org\/10.1017\/cem.2020.403","relation":{},"ISSN":["1481-8035","1481-8043"],"issn-type":[{"type":"print","value":"1481-8035"},{"type":"electronic","value":"1481-8043"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}